Sign In
Get Clay Free →

Suggestions

    Daniel Menichella

    Chief Executive Officer CureVac AG

    Daniel Menichella is a seasoned executive with over 20 years of leadership experience in the pharmaceutical and biotech industries, holding CEO, CBO, SVP, and VP positions.

    He has a proven track record of successful achievements, including multi-billion-dollar in-licensing agreements, IPO launches, M&A initiatives, and partnerships with major companies globally.

    Daniel is known for his strategic planning abilities, driving major deals, conducting due diligence for mergers and acquisitions, and delivering compelling presentations during the business development lifecycle.

    He is a motivational leader, financial analyst, and focused drug developer, having raised significant funds and played key roles in high-value agreements and acquisitions.

    His educational background includes a Master of Business Administration from the University of North Carolina and a Bachelor of Arts from Harvard University, with additional studies in Biotechnology for Business at Duke University.

    Daniel Menichella has held prominent roles such as CEO at LBL Therapeutics, CureVac US Inc, and CureVac AG, as well as Chief Business Officer at various biotech companies and VP positions at renowned pharmaceutical organizations.

    D
    Add to my network

    Location

    Boston, Massachusetts